Explore the feasibility of using spot-scanning proton arc therapy for a synchrotron accelerator-based proton therapy system - A simulation study.
Document Type
Article
Publication Date
9-17-2024
Publication Title
Journal of applied clinical medical physics [electronic resource] / American College of Medical Physics
Abstract
OBJECTIVE: The aim of this study was to evaluate the feasibility and plan quality of spot-scanning proton arc therapy (SPArc) using a synchrotron-accelerator-based proton therapy system compared to intensity-modulated proton therapy (IMPT).
APPROACH: Five representative disease sites, including head and neck, lung, liver, brain chordoma, and prostate cancers, were retrospectively selected. Both IMPT and SPArc plans are generated with the HITACHI ProBEAT PBS system's minimum MU constraints and physics beam model. The SPArc plans are generated with 2.5° sampling frequency. The static delivery time was simulated based on the previously published synchrotron delivery sequence model, and the dynamic delivery time was simulated using a proton arc gantry mechanical model integrated with the synchrotron delivery sequence. Both dosimetric plan quality and delivery efficiency are evaluated.
MAIN RESULTS: A superior plan quality is reached compared with the IMPT plans generated for the same disease site. However, a relatively prolonged static and dynamic delivery time post new challenge, as static time increased by 49.22% and dynamic time 59.10% on average.
SIGNIFICANCE: This study presents the first simulation results of delivering the SPArc plans using a synchrotron-accelerated proton therapy system. The result shows its feasibility and limitations, which could guide future development.
First Page
e14526
Recommended Citation
Cong X, Liu G, Liu P, Zhao L, Chen S, Li X, et al Explore the feasibility of using spot-scanning proton arc therapy for a synchrotron accelerator-based proton therapy system - a simulation study. J Appl Clin Med Phys. 2024 Sep 17:e14526. doi: 10.1002/acm2.14526. Epub ahead of print. PMID: 39287609.
DOI
10.1002/acm2.14526
ISSN
1526-9914
PubMed ID
39287609